An observational study of olanzapine coated and orodispersible tablets effectiveness in schizophrenic and bipolar outpatients FRESH-PEF72-en An observational study of olanzapine coated and orodispersible tablets effectiveness in schizophrenic and bipolar outpatients ZEN FRESH-PEF72-en 72 FRESH-PEF72 LILLY FRANCE Epidemiology France Portal (PEF) AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HEPATITES VIRALES (ANRS MIE) null bipolar disorders olanzapine and duration of treatment Schizophrenia Neurology Psychiatry Behavioral determinants Healthcare system determinants: Use of care Healthcare system determinants The primary objective of this study is to assess the proportion of schizophrenic patients and the proportion of bipolar patients who discontinued olanzapine within 12 months of treatment in outpatient, ambulatory or community settings. null France Germany Greece Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Patients aged 18 years and older, - suffering from bipolar disorders or schizophrenic disorders according to DSM-IV criteria, - initiating or having initiated a treatment via olanzapine in tablet or orodispersible form. Clinical data Participant-reported health data Health event/morbidity Quality of life/health perception Others Other Through independent healthcare practitioners [500-1000[ individuals Interview with the participant (including clinical) Observational Study Observational Study 927 Unknown Restricted access Access on specific project only